Search research articles
Contact Us
Filters
Showing results (51-60 of 69) with videos related to
Page
of 7
Sort By:
Plos Neglected Tropical Diseases
|
September 18, 2015
Global Morbidity and Mortality of Leptospirosis: A Systematic Review
Federico Costa, José E Hagan, Juan Calcagno, et al.
Nature
|
November 4, 2016
Local regulation of gene expression by lncRNA promoters, transcription and splicing
Jesse M Engreitz, Jenna E Haines, Elizabeth M Perez, et al.
Journal of Clinical Epidemiology
|
February 12, 2025
Endpoint assessment via routinely collected data generates estimates comparable to randomized controlled trial data: analysis of a cluster-randomized trial on fall injury prevention
David A Ganz, Erich J Greene, Nancy K Latham, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
April 3, 2024
Validation of a Rule-Based ICD-10-CM Algorithm to Detect Fall Injuries in Medicare Data
David A Ganz, Denise Esserman, Nancy K Latham, et al.
Science (New York, N.Y.)
|
October 7, 2016
Systematic mapping of functional enhancer-promoter connections with CRISPR interference
Charles P Fulco, Mathias Munschauer, Rockwell Anyoha, et al.
American Journal of Clinical Oncology
|
June 1, 2005
Prevention of delayed chemotherapy-induced nausea and vomiting after moderately high to highly emetogenic chemotherapy: comparison of ondansetron, prochlorperazine, and dexamethasone
Celeste Lindley, Susan Goodin, Jeannine McCune, et al.
Plos Neglected Tropical Diseases
|
October 3, 2015
Global Burden of Leptospirosis: Estimated in Terms of Disability Adjusted Life Years
Paul R Torgerson, José E Hagan, Federico Costa, et al.
Neuron
|
February 14, 2007
Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma
Keith L Ligon, Emmanuelle Huillard, Shwetal Mehta, et al.
Pigment Cell & Melanoma Research
|
February 18, 2018
A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma
Janice M Mehnert, Ann W Silk, J H Lee, et al.
Molecular Cancer Therapeutics
|
June 18, 2011
Rationally designed treatment for solid tumors with MAPK pathway activation: a phase I study of paclitaxel and bortezomib using an adaptive dose-finding approach
Janice M Mehnert, Antoinette R Tan, Rebecca Moss, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 69) with videos related to
Sort By:
Page
of 7
Plos Neglected Tropical Diseases
|
September 18, 2015
Global Morbidity and Mortality of Leptospirosis: A Systematic Review
Federico Costa, José E Hagan, Juan Calcagno, et al.
Nature
|
November 4, 2016
Local regulation of gene expression by lncRNA promoters, transcription and splicing
Jesse M Engreitz, Jenna E Haines, Elizabeth M Perez, et al.
Journal of Clinical Epidemiology
|
February 12, 2025
Endpoint assessment via routinely collected data generates estimates comparable to randomized controlled trial data: analysis of a cluster-randomized trial on fall injury prevention
David A Ganz, Erich J Greene, Nancy K Latham, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
April 3, 2024
Validation of a Rule-Based ICD-10-CM Algorithm to Detect Fall Injuries in Medicare Data
David A Ganz, Denise Esserman, Nancy K Latham, et al.
Science (New York, N.Y.)
|
October 7, 2016
Systematic mapping of functional enhancer-promoter connections with CRISPR interference
Charles P Fulco, Mathias Munschauer, Rockwell Anyoha, et al.
American Journal of Clinical Oncology
|
June 1, 2005
Prevention of delayed chemotherapy-induced nausea and vomiting after moderately high to highly emetogenic chemotherapy: comparison of ondansetron, prochlorperazine, and dexamethasone
Celeste Lindley, Susan Goodin, Jeannine McCune, et al.
Plos Neglected Tropical Diseases
|
October 3, 2015
Global Burden of Leptospirosis: Estimated in Terms of Disability Adjusted Life Years
Paul R Torgerson, José E Hagan, Federico Costa, et al.
Neuron
|
February 14, 2007
Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma
Keith L Ligon, Emmanuelle Huillard, Shwetal Mehta, et al.
Pigment Cell & Melanoma Research
|
February 18, 2018
A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma
Janice M Mehnert, Ann W Silk, J H Lee, et al.
Molecular Cancer Therapeutics
|
June 18, 2011
Rationally designed treatment for solid tumors with MAPK pathway activation: a phase I study of paclitaxel and bortezomib using an adaptive dose-finding approach
Janice M Mehnert, Antoinette R Tan, Rebecca Moss, et al.
Page
of 7